🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Invest where the impact begins”: Tremendous session at the BIG-NCTN annual meeting laying out a roadmap for how to nurture and support the next generation of cancer researchers. Dario Trapani Yara Abdou Mariya Rozenblit Ioannis Zerdes Seamus O’Reilly MD PhD Breast International Group

👏👏👏Superb presentation by Drs Abdou, Trapani, Zerdes & Rozenblit Breast International Group National Cancer Institute NCTN mtg funded by The Breast Cancer Research Foundation Eloquent outline of how we can help them impact patient care 👇

Honored to present at the Breast International Group - National Cancer Institute NCTN Annual Meeting in Chicago 🇺🇸, marking 20 years of global collaboration in #breastcancerresearch Many thanks to The Breast Cancer Research Foundation & Drs Seamus O’Reilly MD PhD Nancy Lin, MD Dario Trapani Yara Abdou, MD, MSCR Mariya Rozenblit for an inspiring session! OncoAlert

This was an inspiring talk ProfSiowMingLee 👏👏👏 Lung cancer therapy transformed ✅ Synergy with mRNA vaccines ✅ The ambition of 🇬🇧 cancer research✅ The 💪courage of patients ✅ 🙏G Curigliano MD PhD Dr. E Mittendorf for chairing The Breast Cancer Research Foundation Breast International Group Nancy Lin, MD

Thank you to Dr. David Braun for his great talk at the 2025 #BIG-NCTN Annual Meeting. Here, he explains how cancer vaccines work to treat cancer. National Cancer Institute The Breast Cancer Research Foundation Yale Cancer Center #ASCO25 #vaccines #breastcancer

The voice of Early Career Investigators is heard at the #BIG-NCTN Annual Meetings, Drs Dario Trapani and Ioannis Zerdes are speaking on the need for #younginvestigators ' involvement and support in patient-centered #clinicalresearch. National Cancer Institute The Breast Cancer Research Foundation

Patient Representatives joined the 2025 BIG-NCTN Annual Meeting in Chicago, bringing the patient voice to key talks on #breastcancer research and global collaboration. Eva Schumacher-Wulf shares her experience. National Cancer Institute The Breast Cancer Research Foundation Eva Schumacher-Wulf #ASCO25

BIG-NCTN Collaboration celebrates its 20th anniversary this year and its incredible achievements over the years. Thank you to The Breast Cancer Research Foundation for supporting this longstanding effort. Listen to Dr. Nancy Davidson word, member of the BIG-NCTN Coordinating Group Fred Hutch Cancer Center National Cancer Institute #ASCO25

We are delighted to see Christine Hodgdon, patient advocate co-founder of GRASP and member of the BIG-PPI collaboration, participating in her first BIG-NCTN Annual Meeting. Christine Hodgdon National Cancer Institute The Breast Cancer Research Foundation #ASCO25

Fabulous discussion from Dr. Alexandra Thomas on the evolving evidence for ctDNA across the continuum of breast cancer. Roadmap to understand when and how to use ctDNA in the clinic and what studies are still very much needed before changing practice Breast International Group

📍 Greetings from the ASCO Annual Meeting in Chicago! The BIG-team is on-site at the ASCO Annual Meeting, connecting with global experts, exploring the latest in oncology research, & representing BIG’s commitment to international collaboration in #breastcancer #research.

#ASCO25: Assessment of #breastcancer Index benefit in #premenopausal pts receiving OFS-containing adjuvant #endocrinetherapy was compared btw #SOFT&TEXT cohorts and validation of the prognostic performance of BCI was conducted, go check Poster #150 ETOP IBCSG Partners Foundation Ruth O'Regan

TREAT ctDNA trial A BIG supporter study led by EORTC compares #elacestrant vs. standard ET in ER+/HER2- BC pts with #ctDNA relapse. Enrollment is open in 12 countries and will involve 120 sites. Go check 210b TiP poster presented by Michail ignatiadis at #ASCO25. #bcsm

Happening NOW at #ASCO25 !! Poster 119 presented by Kristina Fanucci on evaluation of treatment-related neutropenia as a predictor of response to adjuvant #palbociclib in the #PALLASTrial ABCSG Alliance Foundation Trials

Happening NOW at #ASCO25 !! Poster presented by Guilherme Nader Marta on long-term outcomes of patients with HER2-positive invasive lobular carcinoma in the #ALTTOtrial ! Go check poster 135! Institut Jules Bordet Instituut Dana-Farber Harvard University

How does HER2+ ILC fare long-term? #ALTTO data ⬆️ CNS relapse risk in ILC vs NST (13.6% vs 5.0%; HR 3.14) – DFS & OS similar despite clinicopathologic differences – Importance of central histology review Poster BD135 | #ASCO25 – come by! OncoAlert

#SOFT&TEXT trials are the result of over 20 years of collaboration. Thank you to patients and their families, HC providers, study chairs and committees, collaborators, the cross-Atlantic groups & the funders. ETOP IBCSG Partners Foundation National Cancer Institute The Breast Cancer Research Foundation #ASCO25

🧬 BIG’s Scientific Director, Virginie Adam, spoke to RTBF about the results from #SERENA-6 presented at #ASCO25. A blood test to detect molecular recurrence + new treatment cut the risk of progression by 56%! 📖 Read more (in FR): rtbf.be/article/cancer…

Finding the answer isn’t always easy. Sometimes, one question takes 20 years. Thank you to the 5738 women, families, clinicians, and teams behind SOFT & TEXT. Your courage built our knowledge. And gave others more time. #BreastCancer #ClinicalTrials #Oncology #Hope #Equity ASCO

💬 Wrapping up an inspiring week at #ASCO25 & the BIG-NCTN Annual Meeting! From 20 years of #BIGNCTN international collaboration to key updates on SOFT/TEXT, ALTTO, TREAT ctDNA & PALLAS. Thank you to all who drive breast cancer research forward! 💗 #BIGAgainstBreastCancer